Oxford Nanopore has initiated its first legal proceedings in Europe against Pacific Biosciences* for infringement of EP1192453, which Oxford Nanopore has an exclusive right to commercialise under a license agreement with Harvard University. *refers to Pacific Biosciences Inc of California and Pacific Biosciences Ltd (UK).
Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, cancer, and genetic disease, today announced the order of ten Illumina NovaSeq 6000 systems to continue to scale its operations in 2017. The first two instruments have now been delivered. Personalis is partnering with leading biopharmaceutical companies to accelerate cancer […]
Empirical Bioscience announced today that they have introduced a new Agarose Gel Extraction Kit that offers a simplified DNA purification process and robust results. Specifically designed to enhance efficiency, the kit arrives with the necessary components including, extraction buffer, activation buffer, washing buffer, elution buffer, spin columns, and collection tubes. Empirical Bioscience’s Agarose Gel Extraction […]
Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA) simultaneously and in real time under tightly controlled atmospheric conditions using open-flow respirometry. The assay […]
BERGISCH GLADBACH – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade. Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – […]
Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, cancer, and genetic disease, today announced the order of ten Illumina NovaSeq 6000 systems to continue to scale its operations in 2017. The first two instruments have now been delivered. Personalis is partnering with leading biopharmaceutical companies to accelerate cancer […]
– Sizes range from 3-liter bench-top to 1000-liter manufacturing scale – Fully scalable system streamlines drug development and production DARMSTADT, Germany — Merck, a leading science and technology company, today announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of […]
SAN DIEGO and CAMBRIDGE, ENGLAND –– Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases, which otherwise can take months or years, while also reducing costs. […]
WALTHAM, MA ThermaGenix, the PCR Improvement Company, announces the completion of a $1.5M Series A-1 financing round. This event adds to several other early achievements at ThermaGenix, including the business formation and licensing agreements, and the establishment of its’ Executive and Scientific Teams. ThermaGenix will use proceeds from the Series A-1 round to: Support commercial […]
MADISON, Wis.–Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cells (iPS), today announced it has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the University to its affiliated hospitals and the biomedical industry. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
